Hongyan Chen1, Yufang Chen1, He Wang2, Yongbo Yang1, Guang Cao2, Xu Yan3
1Eastern Hepatobiliary Surgery Hospital, Shanghai, China; 2Applied Science Lab, GE Healthcare, Shanghai, China; 3East China Normal University, Shanghai, China
This study is a preliminary trial of evaluating treatment response of liver carcinoma based on FDM. 20 patients with liver carcinoma were enrolled in our research. Our results shows the percentage of the increased ADC region and changed ADC region can be robust imaging biomarkers for detection of treatment response in patients with liver carcinoma.